$TOCA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Forte Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Forte Biosciences, Inc.. Get notifications about new insider transactions in Forte Biosciences, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 2021 | TOCA | Forte Biosciences, ... | Riley Antony A | Chief Financial Off ... | Option Exercise | A | 39.66 | 42,500 | 1,685,550 | 42,500 | |
| Apr 13 2021 | TOCA | Forte Biosciences, ... | Wagner Paul A. | See Remarks | Option Exercise | A | 39.66 | 175,000 | 6,940,500 | 175,000 | |
| Jan 14 2021 | TOCA | Forte Biosciences, ... | DARCY THOMAS E | Director | Option Exercise | M | 9.59 | 500 | 4,793 | 0 | |
| Jan 14 2021 | TOCA | Forte Biosciences, ... | DARCY THOMAS E | Director | Buy | M | 9.59 | 500 | 4,793 | 2,358 | 1.9 K to 2.4 K (+26.91 %) |
| Jun 30 2020 | TOCA | Forte Biosciences, ... | Riley Antony A | Chief Financial Off ... | Option Exercise | A | 14.58 | 75,000 | 1,093,500 | 75,000 | |
| Jun 30 2020 | TOCA | Forte Biosciences, ... | Riley Antony A | Chief Financial Off ... | Buy | P | 14.11 | 2,000 | 28,220 | 36,065 | 34.1 K to 36.1 K (+5.87 %) |
| Jun 30 2020 | TOCA | Forte Biosciences, ... | Riley Antony A | Chief Financial Off ... | Buy | P | 14.52 | 4,700 | 68,225 | 34,065 | 29.4 K to 34.1 K (+16.01 %) |
| Jun 29 2020 | TOCA | Forte Biosciences, ... | Wagner Paul A. | See Remarks | Buy | P | 14.48 | 7,000 | 101,356 | 2,279,049 | 2.3 M to 2.3 M (+0.31 %) |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Walker Patricia S | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Williams Donald Allen | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Williams Donald Allen | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Kornfeld Steven | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Kornfeld Steven | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Eichenfield Lawrence | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 17 2020 | TOCA | Forte Biosciences, ... | Eichenfield Lawrence | Director | Option Exercise | A | 18.90 | 30,000 | 567,000 | 30,000 | |
| Jun 15 2020 | TOCA | Tocagen Inc | DARCY THOMAS E | Director | Grant | A | 0.00 | 1,858 | 0 | 1,858 | 0 to 1.9 K |
| Apr 14 2020 | TOCA | Tocagen Inc | Oliveira Steven Michael | 10% Owner | Buy | P | 1.19 | 74,301 | 88,418 | 2,873,450 | 2.8 M to 2.9 M (+2.65 %) |
| Mar 03 2020 | TOCA | Tocagen Inc | Oliveira Steven Michael | 10% Owner | Buy | P | 1.35 | 65,149 | 87,756 | 2,799,149 | 2.7 M to 2.8 M (+2.38 %) |
| Feb 28 2020 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Science& ... | Grant | A | 0.00 | 13,941 | 0 | 23,685 | 9.7 K to 23.7 K (+143.07 %) |
| Oct 04 2019 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Option Exercise | A | 0.64 | 12,500 | 7,989 | 12,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Option Exercise | A | 0.64 | 12,500 | 7,989 | 12,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 0.64 | 30,000 | 19,173 | 30,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 0.64 | 30,000 | 19,173 | 30,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Kabbinavar Fairooz | SVP Clinical Develo ... | Option Exercise | A | 0.64 | 20,000 | 12,782 | 20,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Kabbinavar Fairooz | SVP Clinical Develo ... | Option Exercise | A | 0.64 | 20,000 | 12,782 | 20,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 31,955 | 50,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 31,955 | 50,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | DARCY THOMAS E | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | DARCY THOMAS E | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Science& ... | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Science& ... | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Parkinson David Ross | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Parkinson David Ross | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Jun 03 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | P | 5.15 | 250 | 1,287 | 245,857 | 245.6 K to 245.9 K (+0.10 %) |
| Jun 03 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | P | 5.30 | 3,890 | 20,613 | 245,607 | 241.7 K to 245.6 K (+1.61 %) |
| Jun 03 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | P | 4.59 | 38,860 | 178,414 | 241,717 | 202.9 K to 241.7 K (+19.16 %) |
| May 31 2019 | TOCA | Tocagen Inc | DARCY THOMAS E | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| May 31 2019 | TOCA | Tocagen Inc | Parkinson David Ross | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| May 31 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| May 31 2019 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| May 31 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| May 31 2019 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| May 29 2019 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Grant | A | 8.19 | 732 | 5,995 | 393,478 | 392.7 K to 393.5 K (+0.19 %) |
| May 29 2019 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Grant | A | 8.19 | 703 | 5,758 | 392,746 | 392 K to 392.7 K (+0.18 %) |
| May 29 2019 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Buy | P | 4.30 | 5,000 | 21,475 | 15,042 | 10 K to 15 K (+49.79 %) |
| May 29 2019 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Buy | P | 4.34 | 5,000 | 21,679 | 13,605 | 8.6 K to 13.6 K (+58.11 %) |
| May 29 2019 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Science& ... | Buy | P | 4.56 | 5,000 | 22,783 | 9,744 | 4.7 K to 9.7 K (+105.40 %) |
| Apr 17 2019 | TOCA | Tocagen Inc | Kabbinavar Fairooz | SVP Clinical Develo ... | Option Exercise | A | 9.94 | 100,000 | 994,000 | 100,000 | |
| Feb 26 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Acting-Chief Medica ... | Option Exercise | A | 9.27 | 35,000 | 324,450 | 35,000 | |
| Feb 26 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Acting-Chief Medica ... | Option Exercise | A | 9.27 | 35,000 | 324,450 | 35,000 | |
| Jun 25 2018 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Jun 25 2018 | TOCA | Tocagen Inc | Parkinson David Ross | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Jun 25 2018 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Jun 25 2018 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Jun 25 2018 | TOCA | Tocagen Inc | DARCY THOMAS E | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Jun 25 2018 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Mar 02 2018 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Option Exercise | A | 11.19 | 25,000 | 279,750 | 25,000 | |
| Mar 02 2018 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 11.19 | 85,000 | 951,150 | 85,000 | |
| Mar 02 2018 | TOCA | Tocagen Inc | Das Asha | SVP & Chief Medical ... | Option Exercise | A | 11.19 | 70,000 | 783,300 | 70,000 | |
| Dec 14 2017 | TOCA | Tocagen Inc | Das Asha | SVP & Chief Medical ... | Buy | J | 8.50 | 2,500 | 21,250 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| Dec 14 2017 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Buy | J | 8.50 | 2,500 | 21,250 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Dec 14 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Buy | J | 8.50 | 2,500 | 21,250 | 6,071 | 3.6 K to 6.1 K (+70.01 %) |
| Dec 14 2017 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Research ... | Buy | J | 8.50 | 2,500 | 21,250 | 2,500 | 0 to 2.5 K |
| Dec 14 2017 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Buy | J | 8.50 | 739 | 6,282 | 392,043 | 391.3 K to 392 K (+0.19 %) |
| May 31 2017 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Option Exercise | A | 16.32 | 35,000 | 571,200 | 35,000 | |
| May 31 2017 | TOCA | Tocagen Inc | Das Asha | SVP & Chief Medical ... | Option Exercise | A | 16.32 | 130,000 | 2,121,600 | 130,000 | |
| May 31 2017 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Research ... | Option Exercise | A | 16.32 | 40,000 | 652,800 | 40,000 | |
| May 31 2017 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 16.32 | 85,000 | 1,387,200 | 85,000 | |
| May 31 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 16.32 | 285,000 | 4,651,200 | 285,000 | |
| Apr 21 2017 | TOCA | Tocagen Inc | Das Asha | SVP & Chief Medical ... | Buy | P | 10.00 | 2,500 | 25,000 | 2,500 | 0 to 2.5 K |
| Apr 21 2017 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Buy | P | 10.00 | 5,000 | 50,000 | 5,000 | 0 to 5 K |
| Apr 21 2017 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Research ... | Buy | P | 10.00 | 25,000 | 250,000 | 417,753 | 392.8 K to 417.8 K (+6.37 %) |
| Apr 21 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Buy | J | 10.00 | 3,571 | 35,710 | 3,571 | 0 to 3.6 K |
| Apr 21 2017 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Buy | J | 10.00 | 25,335 | 253,350 | 25,335 | 0 to 25.3 K |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 28,410 | 0 | 0 | |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 161,906 | 0 | 0 | |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Buy | P | 10.00 | 10,000 | 100,000 | 13,623 | 3.6 K to 13.6 K (+276.01 %) |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 3,623 | 0 | 3,623 | 0 to 3.6 K |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 3,623 | 0 | 3,623 | 0 to 3.6 K |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 4,117 | 0 | 4,117 | 0 to 4.1 K |
| Apr 21 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 23,464 | 0 | 23,464 | 0 to 23.5 K |
| Apr 21 2017 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | P | 10.00 | 100,000 | 1,000,000 | 202,857 | 102.9 K to 202.9 K (+97.22 %) |
| Apr 21 2017 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | J | 10.00 | 102,857 | 1,028,570 | 102,857 | 0 to 102.9 K |
| Apr 12 2017 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 10.00 | 4,528 | 45,280 | 4,528 | |
| Apr 12 2017 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 10.00 | 7,246 | 72,460 | 7,246 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Parkinson David Ross | Director | Option Exercise | A | 10.00 | 4,528 | 45,280 | 4,528 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 10.00 | 4,528 | 45,280 | 4,528 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Jolly Douglas | EVP, Research & Pha ... | Option Exercise | A | 10.00 | 14,492 | 144,920 | 14,492 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | A | 10.00 | 10,869 | 108,690 | 10,869 | |
| Apr 12 2017 | TOCA | Tocagen Inc | GRUBER HARRY E | President, Research ... | Option Exercise | A | 10.00 | 27,536 | 275,360 | 27,536 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Duvall Martin J | Chief Executive Off ... | Option Exercise | A | 10.00 | 46,739 | 467,390 | 46,739 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Das Asha | SVP & Chief Medical ... | Option Exercise | A | 10.00 | 7,246 | 72,460 | 7,246 | |
| Apr 12 2017 | TOCA | Tocagen Inc | DARCY THOMAS E | Executive Vice Pres ... | Option Exercise | A | 10.00 | 4,528 | 45,280 | 4,528 |
Page: 1